close

Standard BioTools: Q3 Earnings Snapshot

By Stats Perform Dba Automated Insights 1 min read

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Standard BioTools Inc. (LAB) on Tuesday reported a loss of $21 million in its third quarter.

The South San Francisco, California-based company said it had a loss of 27 cents per share. Losses, adjusted for amortization costs and stock option expense, came to 15 cents per share.

The company that makes equipment to control fluids posted revenue of $25.4 million in the period.

Standard BioTools expects full-year revenue in the range of $100 million to $105 million.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LAB at https://www.zacks.com/ap/LAB

CUSTOMER LOGIN

If you have an account and are registered for online access, sign in with your email address and password below.

NEW CUSTOMERS/UNREGISTERED ACCOUNTS

Never been a subscriber and want to subscribe, click the Subscribe button below.

Starting at $4.79/week.

Subscribe Today